Table 1 Typical MCO-problem formulations for prostate (prescription: 66.6 Gy); EUD: equivalent uniform dose [29], *excluding PTV wall
Constraints | Objectives (slider) | ||
|---|---|---|---|
PTV | Min/ max dose = prescribed dose +/− 15% | PTV | 1) Min dose = prescribed dose |
2) Max dose = prescribed dose | |||
CTV | Min DVH: prescribed dose to 95% volume | CTV | Min dose = prescribed dose |
PTV wall (1 cm ring around PTV) | Max dose = prescribed dose +3% | ||
Rectum/ bladder (excluding CTV) | Max dose = prescribed dose +5% | Rectum/ bladder (excluding CTV) | Dose-fall off: prescribed dose to 0 Gy in 1 cm |
Normal tissue* | Max dose = prescribed dose | Normal tissue | Dose-fall off: prescribed dose to 0 Gy in 1 cm |
Femurs | EUD, a = 2 | ||